NCT02214277 - Cerebral Protection in Transcatheter Aortic Valve Replacement | Biotech Hunter

Enrollment

363

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

June 30, 2016

Conditions

Severe Symptomatic Calcified Native Aortic Valve Stenosis

Interventions

DEVICE

Cerebral Protection System-The SENTINEL System with TAVR

Claret Medical Sentinel Cerebral Protection System is intended for use as an embolic protection system to contain and remove embolic material (thrombus/debris) that may enter the carotid arteries.

DEVICE

TAVR

Trial Locations (15)

Unknown

Cedars-Sinai Medical Center, Los Angeles

Washington Hospital Center, Washington D.C.

Morton Plant Hospital, Clearwater

Emory University Hospital, Atlanta

Henry Ford Hospital, Detroit

Barnes-Jewish Hospital, St Louis

Columbia University Medical Center, New York

Icahn School of Medicine at Mount Sinai, New York

Weill Cornell Medical Center, New York

Cleveland Clinic Foundation, Cleveland

Hospital of the University of Pennsylvania, Philadelphia

UT Houston / Memorial Hermann, Houston

UVA Advanced Cardiac Valve Center, Charlottesville

UW Medical Center, Seattle

04289

Herzzentrum Leipzig - Universitatsklinik, Leipzig